TRAM Snapshot of App at Pub for Oppostn

AMAZE

LEO Pharma A/S

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 88821077 FILING DATE 03/04/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY YARD, JOHN S
L.O. ASSIGNED 115

PUB INFORMATION

RUN DATE 08/14/2020
PUB DATE 09/15/2020
STATUS 681-PUBLICATION/ISSUE REVIEW COMPLETE
STATUS DATE 08/13/2020
LITERAL MARK ELEMENT AMAZE

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT AMAZE
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME LEO Pharma A/S
ADDRESS Industriparken 55
Ballerup, 2750
ENTITY 99-PUBLIC LIMITED COMPANY
CITIZENSHIP Denmark

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and for treatment of the skin
INTERNATIONAL CLASS 038
          DESCRIPTION TEXT Providing online forums for users for the sharing and transmission of information and messages about skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Scientific and medical research in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; Pharmaceutical and scientific research and development services, scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of scientific and pharmaceutical research and development services and scientific research in relation to skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin
INTERNATIONAL CLASS 044
          DESCRIPTION TEXT Medical services in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical and pharmaceutical consultation services and health consultation services, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 038 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 044 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
08/13/2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 010
08/11/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 009
08/11/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 008
08/11/2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
03/31/2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
03/31/2020 GNRT F NON-FINAL ACTION E-MAILED 005
03/31/2020 CNRT R NON-FINAL ACTION WRITTEN 004
03/30/2020 DOCK D ASSIGNED TO EXAMINER 003
03/10/2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
03/07/2020 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY B. Brett Heavner
CORRESPONDENCE ADDRESS B. Brett Heavner
FINNEGAN, HENDERSON, FARABOW, GARRETT &
901 NEW YORK AVENUE N.W.
WASHINGTON DC 20001
DOMESTIC REPRESENTATIVE NONE

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed